Trials / Not Yet Recruiting
Not Yet RecruitingNCT07281274
ADO-5030 in Bronchoconstriction Challenge, Phase 1b
A Single-Center, Single-Arm, Phase 1b Study to Evaluate the Effects of ADO-5030 on a Bronchoconstriction Challenge
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- Sponsor
- Adovate · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a Phase 1 study to learn about the safety and pharmacokinetics of the study drug in patients with asthma and whether the study drug has effect during a respiratory challenge.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ADO-5030 | Single oral dose of ADO-5030. |
Timeline
- Start date
- 2026-01-01
- Primary completion
- 2026-06-01
- Completion
- 2026-07-01
- First posted
- 2025-12-15
- Last updated
- 2026-01-22
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07281274. Inclusion in this directory is not an endorsement.